Alere Blood Clot Test Strip Recall Issued After Warfarin Deaths

|

A Class I recall has been issued for blood clot test strips used during warfarin therapy monitoring, following at least nine reports of problems where the strips producing inaccurate readings, resulting in at least three deaths.  

The Alere INRatio2 PT/INR Professional Blood Clot Test Strips recall was announced on May 6, following at least nine patient injury reports involving readings that indicated significantly lower levels of warfarin clotting, causing at least three patients to suffer severe bleeding that resulted in death.

The INRatio2 PT/INR Professional Test Strips are manufactured by Alere, Inc., and used for the qualitative determination of International Normalized Ratio in fresh capillary whole blood to monitor the effects of warfarin, which is more commonly known by the brand name Coumadin.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Warfarin is a widely used anticoagulant, which prevents the development of blood clots. However, it requires careful monitoring during treatment to maintain an adequate yet safe dose. The test strips allow patients taking the blood thinner warfarin to measure how long it takes blood to clot, preventing an overdose of warfarin that may result in life-threatening hemorrhages.

Alere announced in their recall letter that during the initial stages of the investigation they noticed the INRatio2 PT/INR Professional Test Strips may produce on average between 3.1 to 12.2 INR units lower than INR test results from a local laboratory plasma INR test, resulting in either delays in treatment or the wrong course of treatment.

Alere also announced the root cause for these issues has not been determined but they are working directly with the FDA to understand and resolve the issue.

The test strips were manufactured by Alere Inc., of Waltham, Massachusetts where they were distributed nationwide. Warfarin is a blood thinner used to prevent strokes from atrial fibrillation that has been used for decades. Its use requires careful monitoring to prevent bleeding problems.

The company recommends that customers with recalled INR test strips stop using the products immediately and switch to an alternative method to perform PT/INR testing such as a plasma-based laboratory test, and alternative Alere product, or a different point-of-care monitoring system. Customer should contact Alere at 844-292-5373 or visit them online at www.inr-care.com for instructions on how to return the unused products.

Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. As complication reports rise and more women undergo revision surgery, lawsuits are now being investigated against companies that promoted mesh for off-label breast procedures despite FDA warnings and no breast-specific safety data.
A panel of federal judges will decide in December whether to consolidate all claims brought by parents who allege that Roblox facilitated child sexual exploitation into a multidistrict litigation.
A federal judge has called for a second census of Suboxone tooth decay lawsuits and will require prompt filing of census forms for claims filed from October 1 forward.